Folia Pharmacologica Japonica
Online ISSN : 1347-8397
Print ISSN : 0015-5691
ISSN-L : 0015-5691
Reviews: SGLT Inhibitors: Symptom-Based Drug Discovery and a New Therapeutic Strategy
SGLT2 inhibitor (Luseogliflozin): a new mechanism for treating type 2 diabetes mellitus and therapeutic potential to prevent the progression of diabetic complications
Naoki KojimaYoshishige SamukawaTeisuke Takahashi
Author information
JOURNAL FREE ACCESS

2016 Volume 148 Issue 5 Pages 253-258

Details
Abstract
[in Japanese]
Content from these authors
© 2016 by The Japanese Pharmacological Society
Previous article Next article
feedback
Top